Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ)
CNY 57.39
(-0.92%)
CNY 57.39
(-0.92%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.42 Billion CNY | 5.32% |
| 2022 | 1.35 Billion CNY | 11.99% |
| 2021 | 1.2 Billion CNY | 23.87% |
| 2020 | 975.79 Million CNY | 86.83% |
| 2019 | 522.28 Million CNY | -1.15% |
| 2018 | 528.37 Million CNY | 125.5% |
| 2017 | 234.31 Million CNY | 177.99% |
| 2016 | 84.28 Million CNY | 40.56% |
| 2015 | 59.96 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 298.99 Million CNY | -20.07% |
| 2024 Q1 | 297 Million CNY | -44.26% |
| 2024 Q2 | 374.06 Million CNY | 25.95% |
| 2023 Q4 | 532.84 Million CNY | 60.03% |
| 2023 FY | 1.42 Billion CNY | 5.32% |
| 2023 Q1 | 260.15 Million CNY | -28.89% |
| 2023 Q2 | 333.16 Million CNY | 28.06% |
| 2023 Q3 | 332.97 Million CNY | -0.06% |
| 2022 Q4 | 365.85 Million CNY | -0.61% |
| 2022 FY | 1.35 Billion CNY | 11.99% |
| 2022 Q2 | 368.39 Million CNY | 46.64% |
| 2022 Q1 | 251.22 Million CNY | -47.69% |
| 2022 Q3 | 368.1 Million CNY | -0.08% |
| 2021 Q1 | 221.34 Million CNY | 16.79% |
| 2021 Q4 | 480.26 Million CNY | 126.94% |
| 2021 FY | 1.2 Billion CNY | 23.87% |
| 2021 Q3 | 211.62 Million CNY | -28.37% |
| 2021 Q2 | 295.46 Million CNY | 33.49% |
| 2020 Q1 | 150.73 Million CNY | -39.38% |
| 2020 FY | 975.79 Million CNY | 86.83% |
| 2020 Q2 | 283.32 Million CNY | 87.96% |
| 2020 Q3 | 352.2 Million CNY | 24.31% |
| 2020 Q4 | 189.51 Million CNY | -46.19% |
| 2019 Q3 | 22.05 Million CNY | -82.91% |
| 2019 FY | 522.28 Million CNY | -1.15% |
| 2019 Q4 | 248.64 Million CNY | 1027.31% |
| 2019 Q2 | 129.09 Million CNY | 5.4% |
| 2019 Q1 | 122.48 Million CNY | -0.02% |
| 2018 Q4 | 122.5 Million CNY | 0.0% |
| 2018 FY | 528.37 Million CNY | 125.5% |
| 2017 FY | 234.31 Million CNY | 177.99% |
| 2016 FY | 84.28 Million CNY | 40.56% |
| 2015 FY | 59.96 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Lifecome Biochemistry Co.,Ltd. | -104.74 Million CNY | 1461.046% |
| NanHua Bio-medicine Co., Ltd | 91.94 Million CNY | -1450.511% |
| Shandong Sito Bio-technology Co., Ltd. | 285.54 Million CNY | -399.271% |
| Porton Pharma Solutions Ltd. | 1.43 Billion CNY | 0.8% |
| Zhejiang Wecome Pharmaceutical Company Limited | 261.85 Million CNY | -444.426% |
| Guangdong VTR Bio-Tech Co., Ltd. | 336.9 Million CNY | -323.157% |